These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 3007351

  • 1. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP, Bauer JH, Gaddy P.
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [Abstract] [Full Text] [Related]

  • 2. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
    Reams GP, Bauer JH.
    Drugs; 1985 Apr; 30 Suppl 1():59-69. PubMed ID: 2994988
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of enalapril monotherapy and enalapril/hydrochlorothiazide combination therapy on blood pressure, renal function, and body fluid composition.
    Reams GP, Bauer JH.
    J Clin Hypertens; 1986 Mar; 2(1):55-63. PubMed ID: 3014081
    [Abstract] [Full Text] [Related]

  • 4. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
    Franklin SS, Smith RD.
    Am J Med; 1985 Sep 27; 79(3C):14-23. PubMed ID: 2996342
    [Abstract] [Full Text] [Related]

  • 5. Comparative studies: enalapril versus hydrochlorothiazide as first-step therapy for the treatment of primary hypertension.
    Bauer JH, Jones LB.
    Am J Kidney Dis; 1984 Jul 27; 4(1):55-62. PubMed ID: 6331157
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of lisinopril monotherapy on renal hemodynamics.
    Reams GP, Bauer JH.
    Am J Kidney Dis; 1988 Jun 27; 11(6):499-507. PubMed ID: 2837083
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enalapril in essential hypertension.
    Herrera-Acosta J, Pérez-Grovas H, Fernández M, Arriaga J.
    Drugs; 1985 Jun 27; 30 Suppl 1():35-46. PubMed ID: 2994986
    [Abstract] [Full Text] [Related]

  • 10. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
    Bauer JH.
    Am J Med; 1984 Aug 20; 77(2A):43-51. PubMed ID: 6206722
    [Abstract] [Full Text] [Related]

  • 11. Renal function and hemodynamics during treatment with enalapril in primary hypertension.
    Bauer JH, Reams G, Gaddy P.
    Nephron; 1986 Aug 20; 44 Suppl 1():83-6. PubMed ID: 3018603
    [Abstract] [Full Text] [Related]

  • 12. Time course of changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double-blind randomized study vs hydrochlorothiazide plus propranolol in essential hypertension.
    Semplicini A, Rossi GP, Bongiovì S, Perissinotto F, Samà B, Mozzato MG, Pessina AC.
    Clin Exp Pharmacol Physiol; 1986 Jan 20; 13(1):17-24. PubMed ID: 3011329
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP, Singh A, Logan KW, Holmes RA, Bauer JH.
    J Clin Hypertens; 1987 Jun 20; 3(2):153-63. PubMed ID: 3039075
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.
    Reams GP, Lau A, Knaus V, Bauer JH.
    J Clin Pharmacol; 1993 Apr 20; 33(4):348-53. PubMed ID: 8473550
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E, Gammaro L, Bedogna V, Tonon M, Giorgetti P, Pica B, Antonini P, Tessitore N, Oldrizzi L, Rugiu C.
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec 20; 25(12):656-9. PubMed ID: 2830196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.